Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification
Enrico Caliman, Sara Fancelli, Giulia Petroni, et al.
Lung Cancer (2022) Vol. 175, pp. 88-100
Open Access | Times Cited: 21

Showing 21 citing articles:

Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
Ying Cheng, David R. Spigel, Byoung Chul Cho, et al.
New England Journal of Medicine (2024) Vol. 391, Iss. 14, pp. 1313-1327
Closed Access | Times Cited: 54
Small cells – big issues: biological implications and preclinical advancements in small cell lung cancer
Anna Solta, Büsra Ernhofer, Kristiina Boettiger, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Real-world evidence in extensive disease small cell lung cancer: The missing piece of the puzzle
P. Damiano, Alessio Stefani, Alice Avancini, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104618-104618
Open Access | Times Cited: 1
Current and future therapies for small cell lung carcinoma
Xiaoqian Zhai, Zhengkun Zhang, Yuxin Chen, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1
The emerging role of Schlafen-11 (SLFN11) in predicting response to anticancer treatments: Focus on small cell lung cancer
Daniela Scattolin, Alessandro Dal Maso, Alessandra Ferro, et al.
Cancer Treatment Reviews (2024) Vol. 128, pp. 102768-102768
Closed Access | Times Cited: 5
Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer
Man Wang, Lijie Zhu, Xiaoxu Yang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Efficacy and safety of novel immune checkpoint inhibitor‐based combinations versus chemotherapy as first‐line treatment for patients with extensive‐stage small cell lung cancer: A network meta‐analysis
Chuang Yang, Tiantian Xuan, Qing Gong, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 15, pp. 1246-1262
Open Access | Times Cited: 4
Small Cell Lung Cancer Unveiled: Exploring the Untapped Resource of Circulating Tumor Cells-Derived Organoids
Jesús A. Pérez-Cabello, Ana Artero‐Castro, Sonia Molina‐Pinelo
Critical Reviews in Oncology/Hematology (2025), pp. 104622-104622
Closed Access
Caractérisation moléculaire des cancers du poumon : mise au point et recommandations
Simon Garinet, Audrey Mansuet‐Lupo, Diane Damotte, et al.
Bulletin du Cancer (2025) Vol. 112, Iss. 3, pp. 3S16-3S23
Closed Access
Dynamic evolution and antitumor mechanisms of CXCR6+CD8+ T cells in small cell lung cancer treated with low-dose radiotherapy and immunotherapy
Guo Lin, Zhuoran Yao, Kai Kang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Longitudinal detection of subcategorized CD44v6+ CTCs and circulating tumor endothelial cells (CTECs) enables novel clinical stratification and improves prognostic prediction of small cell lung cancer: A prospective, multi-center study
Ying Wang, Lína Zhang, Jinjing Tan, et al.
Cancer Letters (2023) Vol. 571, pp. 216337-216337
Open Access | Times Cited: 9
Rictor—A Mediator of Progression and Metastasis in Lung Cancer
Fatime Szalai, Dániel Sztankovics, Ildikó Krencz, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 543-543
Open Access | Times Cited: 3
EBV-positive small cell neuroendocrine carcinoma of nasopharynx as a probably unique subtype of neuroendocrine carcinoma: a clinicopathologic study of three cases and literature review
Ying Chen, Ning Zhou, Caijun Huang, et al.
Diagnostic Pathology (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Immunotherapy in Combination with Chemotherapy for Triple-negative Breast Cancer
E Solano, Jazmín Cristina Stevens Barrón, Christian Chapa González
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 4, pp. 431-439
Closed Access | Times Cited: 7
Abnormal expression of Krüppel-like transcription factors and their potential values in lung cancer
Yang Shi, Min Yao, Shuijie Shen, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28292-e28292
Open Access | Times Cited: 1
Navigating the Complexity of Resistance in Lung Cancer Therapy: Mechanisms, Organoid Models, and Strategies for Overcoming Treatment Failure
Da Hyun Kang, Jisoo Lee, Subin Im, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 3996-3996
Open Access | Times Cited: 1
Disseminated tumor cells in bone marrow as predictive classifiers for small cell lung cancer patients
Ying Wang, Jingying Nong, Baohua Lu, et al.
Journal of the National Cancer Center (2024) Vol. 4, Iss. 4, pp. 335-345
Open Access
Patients with Extensive-Stage Small Cell Lung Cancer Harboring Less Than 4 Metastatic Sites May Benefit from Immune Checkpoint Inhibitor Rechallenge by Reshaping Tumor Microenvironment
Xiaoling Shang, Chenyue Zhang, Yuanyuan Lv, et al.
ImmunoTargets and Therapy (2024) Vol. Volume 13, pp. 571-583
Open Access
Prior antibiotics, proton pump inhibitors, and probiotics in patients with extensive stage small cell lung cancer treated with immune checkpoint blockade: A post‐hoc analysis of the phase I/III IMpower 133 trial
Kazuki Takada, Shinkichi Takamori, Mototsugu Shimokawa, et al.
International Journal of Cancer (2024) Vol. 156, Iss. 5, pp. 914-919
Closed Access
A review of the immunomodulatory properties of mesenchymal stem cells and their derived extracellular vesicles in small-cell and non-small-cell lung cancer cells
Radhwan Abdul Kareem, Hayder Naji Sameer, Ahmed Yaseen, et al.
International Immunopharmacology (2024) Vol. 146, pp. 113848-113848
Closed Access
A549 Alveolar Carcinoma Spheroids as a Cytotoxicity Platform for Carboxyl‐ and Amine‐Polyethylene Glycol Gold Nanoparticles
Melissa Petzer, Seth‐Frerich Fobian, Mary Gulumian, et al.
Pharmacology Research & Perspectives (2024) Vol. 13, Iss. 1
Open Access
ERCC1 and ERCC2 genes expression and their SNPs variants identify a favorable signature for SCLC patients treated with platinum-based chemotherapy
Enrico Caliman, Sara Fancelli, Federico Scolari, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top